查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1806504

全球 IVF 市场（按产品类型、胚胎来源、程序类型、应用和最终用户）：预测（2025-2030 年）

In-Vitro Fertilization Market by Product, Embryo Source, Procedure Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计 IVF 市场规模到 2024 年将达到 121.7 亿美元，到 2025 年将达到 134 亿美元，到 2030 年将达到 221 亿美元，复合年增长率为 10.45%。

主要市场统计数据
预测年份（2024年） 121.7亿美元
基准年（2025年） 134亿美元
预测年份（2030年） 221亿美元
复合年增长率（%） 10.45%

新兴趋势和未满足的需求推动体外受精领域的创新、可及性和以患者为中心的解决方案

体外受精（IVF）领域已从最初的实验阶段发展成为生殖医学的基石，致力于应对复杂的生物学、伦理学和经济学挑战。受孕延迟和不孕症上升等人口趋势变化的推动，该市场对先进实验室能力和个人化治疗通讯协定的需求日益增长。胚胎培养和冷冻保存的技术创新正在提高成功率，而不断发展的法律规范则持续影响医疗服务的可近性和报销途径。患者的期望也在不断变化。如今的准父母需要透明的治疗结果指标、微创治疗方法以及能够即时更新治疗过程的数位互动工具。

技术突破与以患者为中心的策略相结合，正在重新定义全球 IVF 成功指标和获取模式

在实验室自动化、数位监控和精准医疗领域取得突破的推动下，试管婴儿 (IVF) 产业正在经历变革时期。互联平台与云端基础资料管理的整合，使得远端监控孵化器和预测胚胎活力的分析仪錶板成为可能。此外，人工智慧演算法正在开创预测成功率模型的新范式，增强胚胎学家对胚胎进行分级的专业知识。随着这些技术进步，医疗服务提供者正在采用以患者为中心的策略，提供远距健康咨询、个人化卵巢刺激方案和客製化的基因分析服务。

预计 2025 年的关税调整将促使美国IVF 供应商重组其供应链、成本结构和战略计划

2025年，美国新近颁布的针对进口培养基套件、一次性用品和专用检测设备的关税，为试管婴儿（IVF）提供者带来了巨大的阻力。这些调整扰乱了长期存在的供应链，促使供应商重新谈判合同，并促使企业投资于国内冷冻保存培养基和显微操作仪器的生产设施。随着进口成本的上升，诊所面临着要么消化增加的成本，要么透过调整服务费用转嫁成本的压力，这加剧了对成本效益和临床差异化服务的竞争。

对产品供应、胚胎采购选项、手术方式、临床应用和最终用户管道的全面分析突出了机会

从产品类型来看，培养基（包括冷冻保存培养基、胚胎培养製剂、卵子处理液和精子处理试剂）由于直接影响实验室结果，继续成为研发投资的重点。同时，微流体晶片和一次性移液器等一次性设备和配件因其能够提高操作无菌性并最大限度地降低交叉污染风险而备受关注。对于寻求操作一致性的实验室而言，诸如隔振台、低温系统、气体分析仪、高级成像平台、培养箱、体外受精柜、雷射系统、显微操作套件、显微镜、抽吸泵、精子分析仪、分离器和目击追踪解决方案等设备类别仍然至关重要。

美洲、欧洲、中东和非洲地区以及亚太地区不同的区域动态和法规环境推动了独特的成长模式和投资重点

美洲地区展现出成熟的市场特征，拥有完善的报销途径、对监管协调的承诺以及对个人化生育治疗解决方案的关注。尤其是美国的诊所，它们正在利用远端医疗和直接面向消费者的基因检测来差异化其服务，而加拿大的医疗服务提供者则受益于公共资助模式。相较之下，欧洲、中东和非洲地区的特点是各国法规纷繁复杂，从西欧严格的胚胎检测法到中东对不孕症治疗旅游中心日益增长的投资，再到一些非洲国家尚处于服务发展的早期阶段，不一而足。该地区的医疗保健提供者必须应对复杂的合规环境，同时充分利用跨境患者流量。

领先产业参与者的策略定位和创新组合揭示了体外受精领域的竞争进步和伙伴关係趋势

体外受精 (IVF) 市场的主要企业正透过策略性地多元化产品平臺和扩展服务网络来脱颖而出。跨国生命科学公司正在透过先进的冷冻保存解决方案和人工智慧胚胎选择平台来扩充其产品组合，而生殖医学专家则继续投资于显微操作技术和照护现场诊断检测。一些主要企业正在收购区域性连锁实验室，以获得直接获取临床工作流程和检体量的管道，并强化其端到端服务模式。

为产业领导者提供可行的策略，以优化营运、促进合作并利用新兴的 IVF机会

产业领导者应优先考虑供应链多元化，与国内培养基和设备伙伴关係合作，以减轻关税波动的影响。投资用于胚胎活力评估和实验室工作流程自动化的人工智慧，可以显着提高临床效率，缩短怀孕时间。扩展远端医疗和远端监控能力，可以满足患者对便利性的需求，并增强整个治疗週期的连续性。

一个强大的多阶段研究框架，整合了主要专家参与、二手资料检验和定量情境分析

研究途径采用多阶段框架，首先对50多位生育专家、胚胎学家、实验室主任和设备製造商进行深入访谈，以了解他们对技术应用和临床挑战的第一手观点。之后，研究人员进行了二次研究，全面回顾了同行评审期刊、监管文件、专利资料库和已发表的临床指南，检验并强化定性见解。

技术进步、监管影响和市场动态的综合展现了全球 IVF 的发展路径和未来前景

试管婴儿（IVF）产业整体呈现了技术创新、监管格局演变以及患者期望之间复杂的相互作用，这些因素共同塑造着其未来的发展轨迹。先进的培养基和冷冻保存技术正在为实验室性能树立新的标桿，而人工智慧和数位健康平台则正在重新定义患者参与和临床决策支援。美国关税政策的连锁反应正在推动供应链重组，鼓励国内生产，并凸显了韧性和适应性的重要性。

目录

第一章 引言

第二章 分析方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 试管婴儿实验室越来越多地使用人工智慧胚胎选择和缩时摄影来优化植入率。
  • 受职场不孕不育福利和社会趋势的推动，选择性卵子冷冻服务蓬勃发展
  • 为希望在治疗前保留生育能力的癌症患者扩大菲达起司项目
  • 可携式照护现场婴儿系统的出现，使新兴市场能够实现分散式不孕症治疗
  • 越来越多地采用 PGT-A 检测服务来减少基因异常并改善治疗效果
  • 整合远端医疗和数位健康平台，实现远距IVF咨询和监测
  • 加强生育诊所和基因检测实验室之间的合作，以进行个体化胚胎评估

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章：美国关税的累积影响（2025年）

第 8 章 IVF 市场：依产品分类

  • 培养基
    • 冷冻保存培养基
    • 胚胎培养基
    • 卵子处理介质
    • 精子处理培养基
  • 一次性设备和配件
  • 装置
    • 防震台
    • 低温保存系统
    • 气体分析仪
    • 影像分析系统
    • 培养箱
    • 试管婴儿柜
    • 雷射系统
    • 微作业系统
    • 显微镜
    • 卵子吸泵
    • 精子分析系统
    • 精子分离装置
    • 检体管理系统

第九章 IVF市场：依胚胎来源

  • 新捐款者
  • 新的非捐赠者
  • 冻结捐赠者
  • 冷冻非捐赠者

第 10 章体外受精市场（依程序类型）

  • 辅助孵化
  • 常规试管婴儿
  • 冷冻胚胎移植（FET）
  • 配子输卵管植入（GIFT）
  • 卵细胞质内单一精虫显微注射术（ICSI）
  • 受精卵输卵管内移植（ZIFT）

第 11 章 IVF 市场：依应用

  • 女性不孕症
    • 子宫内膜异位症
    • 排卵障碍
    • 输卵管因素不孕
    • 不明原因的不孕症
  • 男性不孕
    • 精子形态异常
    • 少精子症
    • 精子活力低

第 12 章：体外受精市场（依最终用户）

  • 门诊手术中心
  • 不孕不育诊所
  • 医院

13. 美国试管婴儿市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

14. 欧洲、中东和非洲试管婴儿市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

15. 亚太地区试管婴儿市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十六章竞争格局

  • 市场占有率分析（2024年）
  • FPNV定位矩阵（2024年）
  • 竞争分析
    • Carl Zeiss AG
    • Cook Medical Inc.
    • CooperSurgical Inc.
    • Corning incorporated
    • Ferring BV
    • Esco micro pte. Ltd.
    • FertiPro NV
    • Genea Biomedx Pty Ltd.
    • Hamilton Thorne, Inc.
    • INVO Bioscience, Inc.
    • IVFtech ApS
    • Kitazato Corporation
    • Laboratoire CCD
    • Merck KGaA
    • Nidacon International AB
    • Nikon Corporation
    • Olympus Corporation
    • Thermo Fisher Scientific Inc.
    • Vitrolife AB
    • Meiji Techno Co., Ltd.

第十七章 研究人工智慧

第十八章 研究统计

第十九章 研究联络人

第二十章 研究报导

第21章 附录

Product Code: MRR-43127F7279FE

The In-Vitro Fertilization Market was valued at USD 12.17 billion in 2024 and is projected to grow to USD 13.40 billion in 2025, with a CAGR of 10.45%, reaching USD 22.10 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 12.17 billion
Estimated Year [2025] USD 13.40 billion
Forecast Year [2030] USD 22.10 billion
CAGR (%) 10.45%

Emerging Trends and Unmet Needs Propel Innovation, Accessibility, and Patient-Centric Solutions Across the In-Vitro Fertilization Landscape

The in-vitro fertilization discipline has emerged from its experimental origins to become a cornerstone of reproductive health, addressing complex biological, ethical, and economic challenges. Driven by shifting demographic trends such as delayed parenthood and rising infertility rates, the market is witnessing heightened demand for advanced laboratory capabilities and personalized treatment protocols. Technological innovations in embryo culture and cryopreservation have expanded success rates, while evolving regulatory frameworks continue to shape accessibility and reimbursement pathways. Patient expectations are also evolving; today's prospective parents seek transparent outcome metrics, minimally invasive procedures, and digital engagement tools that deliver real-time updates on their treatment journey.

Simultaneously, the convergence of data analytics and artificial intelligence is revolutionizing embryo selection and laboratory workflow optimization, reducing time to pregnancy and improving consistency of outcomes. As competition intensifies among clinics, device manufacturers, and service providers, strategic collaboration and vertical integration are gaining traction as means to control quality and manage costs. In this milieu, ethical considerations surrounding genetic testing and embryo manipulation further underscore the need for robust governance and practitioner training. Altogether, these dynamics set the stage for an era of innovation where patient-centric solutions, operational excellence, and scientific rigor will define leadership in the in-vitro fertilization arena.

Technological Breakthroughs Combined with Patient-Centric Strategies Are Redefining Success Metrics and Access Models in In-Vitro Fertilization Globally

The in-vitro fertilization sector is undergoing a transformative shift fueled by breakthroughs in laboratory automation, digital monitoring, and precision medicine. Integration of connectivity platforms and cloud-based data management is enabling remote monitoring of incubators and analytic dashboards that forecast embryo viability. Furthermore, artificial intelligence algorithms are augmenting embryologists' expertise in grading embryos, ushering in a new paradigm of predictive success modeling. Alongside these technological advances, providers are embracing patient-centric strategies that offer telehealth consultations, personalized ovarian stimulation regimens, and tailored genetic profiling services.

In parallel, the industry is witnessing a consolidation wave among clinics and laboratory suppliers, driven by the pursuit of scale efficiencies and broader geographic coverage. Mergers and strategic alliances are creating regional and global networks that facilitate standardized protocols and pooled resources for research and development. Meanwhile, emerging markets in Asia and South America are recalibrating their regulatory and reimbursement policies to encourage domestic investment and medical tourism. As demand diversifies-with growing awareness of male factor infertility and the rise of fertility preservation among cancer survivors-stakeholders are called upon to innovate across both product and service dimensions, ensuring that clinical excellence and equitable access advance hand in hand.

Projected Tariff Adjustments in 2025 Are Reshaping Supply Chains, Cost Structures, and Strategic Planning for U.S. In-Vitro Fertilization Providers

In 2025, newly enacted U.S. tariffs on imported culture media kits, disposable devices, and specialized laboratory equipment introduced significant headwinds for in-vitro fertilization providers. These adjustments disrupted long-standing supply chains, prompted renegotiation of vendor contracts, and catalyzed investment in domestic manufacturing facilities for cryopreservation media and micromanipulation instruments. As import costs rose, clinics faced pressure to absorb incremental expenses or pass them along through adjusted service fees, intensifying competition on cost efficiency and clinical differentiation.

To mitigate these challenges, many providers established strategic partnerships with local suppliers capable of producing laser systems, incubators, and anti-vibration tables at scale. Others accelerated adoption of modular laboratory designs that allow equipment sharing across service lines, optimizing utilization and reducing capital intensity. Moreover, the tariff environment has spurred exploration of alternate sourcing options, including collaborative R&D agreements with regional biotechnology firms. While these shifts initially introduced complexity, they ultimately fostered supply chain resilience, incentivized innovation in product design, and reinforced the strategic imperative for fertility centers to adopt agile procurement and long-term strategic planning.

Comprehensive Analysis of Product Offerings, Embryo Sourcing Options, Procedure Modalities, Clinical Applications, and End-User Channels Reveals Opportunities

A nuanced examination of product categories reveals that culture media-encompassing cryopreservation media, embryo culture formulations, ovum processing solutions, and sperm processing reagents-continues to command R&D investment due to its direct impact on laboratory outcomes. Alongside this, disposable devices and accessories such as microfluidic chips and single-use transfer pipettes are gaining prominence by enhancing procedural sterility and minimizing cross-contamination risks. The equipment segment, featuring anti-vibration tables, cryosystems, gas analyzers, advanced imaging platforms, incubators, IVF cabinets, laser systems, micromanipulation suites, microscopes, aspiration pumps, sperm analyzers, separation devices, and witness tracking solutions, remains critical for laboratories seeking operational consistency.

Insights into embryo sourcing highlight a dynamic balance between fresh donor and non-donor cycles and the growing prevalence of frozen donor and non-donor transfers, driven by patient preference for cycle flexibility and single embryo transfer protocols. Procedure-type analysis underscores the sustained dominance of conventional IVF and intracytoplasmic sperm injection, complemented by rising adoption of frozen embryo transfer, assisted hatching, gamete intrafallopian transfer, and zygote intrafallopian transfer techniques. In terms of clinical application, female infertility segments such as endometriosis, ovulatory disorders, tubal factor infertility, and unexplained infertility represent the majority of treatment volumes, while male infertility categories-including abnormal sperm morphology, low sperm count, and poor motility-constitute an under-addressed opportunity. Ambulatory surgery centers, fertility clinics, and hospitals collectively define the end-user landscape, each bringing distinct procedural workflows, reimbursement frameworks, and patient engagement models.

Distinct Regional Dynamics and Regulatory Environments Drive Unique Growth Patterns and Investment Priorities Across Americas, EMEA, and Asia-Pacific

The Americas region exhibits mature market characteristics, with established reimbursement pathways, regulatory harmonization efforts, and a focus on personalized fertility solutions. U.S. clinics, in particular, are leveraging telehealth and direct-to-consumer genetic testing to differentiate their services, while Canadian providers benefit from supportive public funding models. In contrast, the Europe, Middle East & Africa corridor encompasses a mosaic of national regulations, ranging from stringent embryo testing laws in Western Europe to growing investment in fertility tourism hubs in the Middle East and nascent service development in select African nations. Providers in this region must navigate complex compliance landscapes while capitalizing on cross-border patient flows.

Asia-Pacific stands out as the fastest-growing region, propelled by government initiatives in China and India that expand fertility treatment accessibility and catalyze local manufacturing of laboratory consumables and instruments. Japan and South Korea are enhancing regulatory frameworks to incorporate advanced genetic diagnostics, and Australia and New Zealand maintain high standards for clinical accreditation and laboratory quality. Across these regions, varying demographic profiles, cultural attitudes toward fertility, and reimbursement mechanisms create differentiated growth trajectories, underscoring the necessity for targeted entry strategies and localized value propositions.

Strategic Positioning and Innovation Portfolios of Leading Industry Players Illuminate Competitive Advancements and Partnership Trends in In-Vitro Fertilization

Leading organizations in the in-vitro fertilization market are distinguishing themselves through strategic diversification of their product pipelines and expansion of service networks. Multinational life science firms have augmented their portfolios with advanced cryopreservation solutions and AI-enabled embryo selection platforms, while specialized reproductive health companies continue to invest in micromanipulation technologies and point-of-care diagnostic assays. Several key players have pursued acquisition of regional laboratory chains to secure direct access to clinic workflows and specimen volumes, reinforcing end-to-end service models.

Collaborations between equipment manufacturers and fertility providers have introduced bundled offerings that integrate hardware, consumables, and data analytics in subscription-based frameworks. Concurrently, cross-industry partnerships with genetic testing companies are facilitating seamless integration of preimplantation genetic screens. Emerging players have differentiated through agile product development cycles and localized manufacturing strategies, particularly in Asia-Pacific markets. Taken together, these competitive dynamics illustrate a landscape where technological prowess, strategic alliances, and nimble go-to-market approaches will dictate market leadership and shape the next wave of innovation.

Actionable Strategies for Industry Leaders to Optimize Operations, Foster Collaboration, and Capitalize on Emerging In-Vitro Fertilization Opportunities

Industry leaders should prioritize diversification of their supply chains by forging partnerships with domestic media and equipment suppliers to mitigate exposure to tariff fluctuations. Investing in artificial intelligence for embryo viability assessment and laboratory workflow automation can yield measurable improvements in clinical efficiency and reduce time to pregnancy. Expanding telehealth and remote monitoring capabilities will cater to patient demand for convenience and strengthen retention across treatment cycles.

Providers are encouraged to cultivate collaborative ecosystems with academic research centers and technology startups to accelerate innovation in genetic diagnostics and cryopreservation methodologies. Implementing lean manufacturing principles for consumables and adopting modular laboratory architectures can optimize capital allocation and enhance scalability. To address emerging male infertility demands, organizations should integrate targeted diagnostic services and specialized treatment protocols into their offerings. Finally, proactive monitoring of evolving regulatory requirements across key regions will enable agile compliance and future-proofed market entry strategies.

Robust Multi-Phase Research Framework Integrating Primary Expert Engagement, Secondary Data Validation, and Quantitative Scenario Analysis

The research approach employs a multi-phase framework that began with in-depth interviews conducted with over fifty fertility specialists, embryologists, laboratory directors, and equipment manufacturers to capture first-hand perspectives on technological adoption and clinical challenges. Following these discussions, secondary research encompassed a comprehensive review of peer-reviewed journals, regulatory filings, patent databases, and published clinical guidelines to validate and augment qualitative insights.

Quantitative analysis was performed through scenario modeling to assess the impact of tariff changes and regional regulatory variations on cost structures and adoption rates. Data triangulation techniques reconciled findings across primary and secondary sources, ensuring consistency and rigor. Furthermore, expert panels convened throughout the process provided iterative validation of assumptions, while internal peer review and methodological audits guaranteed transparency and reproducibility. Ethical considerations, data privacy protocols, and quality control measures underpinned each stage to deliver robust and credible market intelligence.

Synthesis of Technological Advances, Regulatory Impacts, and Market Dynamics Illustrates the Evolutionary Path and Future Outlook of Global In-Vitro Fertilization

In synthesizing the landscape of in-vitro fertilization, it becomes evident that technological innovation, regulatory evolution, and patient expectations are intricately interwoven in shaping future trajectories. Advanced culture media and cryopreservation techniques are setting new benchmarks for laboratory performance, while artificial intelligence and digital health platforms are redefining patient engagement and clinical decision support. The ripple effects of U.S. tariff policies have prompted supply chain realignment and encouraged domestic production, underscoring the importance of resilience and adaptability.

Segmentation analysis highlights the criticality of aligning product offerings with emerging procedural preferences and clinical applications, particularly in under-addressed male infertility categories. Regional insights reveal that tailored market entry strategies and local partnerships will be essential to capitalize on diverse growth drivers. Competitive dynamics among leading players demonstrate that integrated service models, strategic alliances, and agile manufacturing approaches will determine market leadership. As stakeholders navigate these converging trends, a steadfast focus on operational excellence, ethical governance, and patient-centric innovation will chart the course for sustained success in the global in-vitro fertilization sector.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Increasing use of AI-driven embryo selection and time-lapse imaging in IVF labs to optimize implantation rates
  • 5.2. Rapid growth in elective egg freezing services fueled by workplace fertility benefits and social trends
  • 5.3. Expansion of oncofertility programs for cancer patients seeking fertility preservation before treatment
  • 5.4. Emergence of portable point-of-care IVF systems enabling decentralized fertility treatments in emerging markets
  • 5.5. Rising implementation of PGT-A testing services to reduce genetic abnormalities and improve outcomes
  • 5.6. Integration of telemedicine and digital health platforms for remote IVF consultations and monitoring
  • 5.7. Increasing collaboration between fertility clinics and genetic testing labs for personalized embryo assessment

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. In-Vitro Fertilization Market, by Product

  • 8.1. Introduction
  • 8.2. Culture Media
    • 8.2.1. Cryopreservation Media
    • 8.2.2. Embryo Culture Media
    • 8.2.3. Ovum Processing Media
    • 8.2.4. Sperm Processing Media
  • 8.3. Disposable Devices & accessories
  • 8.4. Equipment
    • 8.4.1. Anti-vibration Tables
    • 8.4.2. Cryosystems
    • 8.4.3. Gas Analyzers
    • 8.4.4. Imaging Systems
    • 8.4.5. Incubators
    • 8.4.6. IVF Cabinets
    • 8.4.7. Laser Systems
    • 8.4.8. Micromanipulator Systems
    • 8.4.9. Microscopes
    • 8.4.10. Ovum Aspiration Pumps
    • 8.4.11. Sperm Analyzer Systems
    • 8.4.12. Sperm Separation Devices
    • 8.4.13. Witness Systems

9. In-Vitro Fertilization Market, by Embryo Source

  • 9.1. Introduction
  • 9.2. Fresh Donor
  • 9.3. Fresh Non-donor
  • 9.4. Frozen Donor
  • 9.5. Frozen Non-donor

10. In-Vitro Fertilization Market, by Procedure Type

  • 10.1. Introduction
  • 10.2. Assisted Hatching
  • 10.3. Conventional IVF
  • 10.4. Frozen Embryo Transfer (FET)
  • 10.5. Gamete Intrafallopian Transfer (GIFT)
  • 10.6. Intracytoplasmic Sperm Injection (ICSI)
  • 10.7. Zygote Intrafallopian Transfer (ZIFT)

11. In-Vitro Fertilization Market, by Application

  • 11.1. Introduction
  • 11.2. Female Infertility
    • 11.2.1. Endometriosis
    • 11.2.2. Ovulatory Disorders
    • 11.2.3. Tubal Factor Infertility
    • 11.2.4. Unexplained Infertility
  • 11.3. Male Infertility
    • 11.3.1. Abnormal Sperm Morphology
    • 11.3.2. Low Sperm Count
    • 11.3.3. Poor Sperm Motility

12. In-Vitro Fertilization Market, by End User

  • 12.1. Introduction
  • 12.2. Ambulatory Surgery Centers
  • 12.3. Fertility Clinics
  • 12.4. Hospitals

13. Americas In-Vitro Fertilization Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa In-Vitro Fertilization Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific In-Vitro Fertilization Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Carl Zeiss AG
    • 16.3.2. Cook Medical Inc.
    • 16.3.3. CooperSurgical Inc.
    • 16.3.4. Corning incorporated
    • 16.3.5. Ferring B.V.
    • 16.3.6. Esco micro pte. Ltd.
    • 16.3.7. FertiPro N.V.
    • 16.3.8. Genea Biomedx Pty Ltd.
    • 16.3.9. Hamilton Thorne, Inc.
    • 16.3.10. INVO Bioscience, Inc.
    • 16.3.11. IVFtech ApS
    • 16.3.12. Kitazato Corporation
    • 16.3.13. Laboratoire CCD
    • 16.3.14. Merck KGaA
    • 16.3.15. Nidacon International AB
    • 16.3.16. Nikon Corporation
    • 16.3.17. Olympus Corporation
    • 16.3.18. Thermo Fisher Scientific Inc.
    • 16.3.19. Vitrolife AB
    • 16.3.20. Meiji Techno Co., Ltd.

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. IN-VITRO FERTILIZATION MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. IN-VITRO FERTILIZATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. IN-VITRO FERTILIZATION MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. IN-VITRO FERTILIZATION MARKET: RESEARCHAI
  • FIGURE 26. IN-VITRO FERTILIZATION MARKET: RESEARCHSTATISTICS
  • FIGURE 27. IN-VITRO FERTILIZATION MARKET: RESEARCHCONTACTS
  • FIGURE 28. IN-VITRO FERTILIZATION MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. IN-VITRO FERTILIZATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CRYOPRESERVATION MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CRYOPRESERVATION MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO CULTURE MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO CULTURE MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVUM PROCESSING MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVUM PROCESSING MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM PROCESSING MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM PROCESSING MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY DISPOSABLE DEVICES & ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY DISPOSABLE DEVICES & ACCESSORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ANTI-VIBRATION TABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ANTI-VIBRATION TABLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CRYOSYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CRYOSYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GAS ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GAS ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY INCUBATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY IVF CABINETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY IVF CABINETS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MICROSCOPES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVUM ASPIRATION PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVUM ASPIRATION PUMPS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM ANALYZER SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM ANALYZER SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM SEPARATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM SEPARATION DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY WITNESS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY WITNESS SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FRESH DONOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FRESH DONOR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FRESH NON-DONOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FRESH NON-DONOR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN DONOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN DONOR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN NON-DONOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN NON-DONOR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ASSISTED HATCHING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ASSISTED HATCHING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CONVENTIONAL IVF, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CONVENTIONAL IVF, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN EMBRYO TRANSFER (FET), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN EMBRYO TRANSFER (FET), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER (GIFT), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER (GIFT), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION (ICSI), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION (ICSI), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ZYGOTE INTRAFALLOPIAN TRANSFER (ZIFT), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ZYGOTE INTRAFALLOPIAN TRANSFER (ZIFT), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVULATORY DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVULATORY DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY TUBAL FACTOR INFERTILITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY TUBAL FACTOR INFERTILITY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY UNEXPLAINED INFERTILITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY UNEXPLAINED INFERTILITY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ABNORMAL SPERM MORPHOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ABNORMAL SPERM MORPHOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY LOW SPERM COUNT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY LOW SPERM COUNT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY POOR SPERM MOTILITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY POOR SPERM MOTILITY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 111. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 113. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 115. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 117. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 119. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 121. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 123. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 125. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 127. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 129. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 131. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 132. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 133. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 134. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 135. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 136. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 137. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 138. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 139. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 141. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 143. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 144. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 145. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 146. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 147. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 149. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 150. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 151. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 152. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 153. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 154. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 155. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 156. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 157. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 158. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 159. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 161. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 163. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 164. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 165. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 166. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 167. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 168. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 169. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 170. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 171. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 172. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 173. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 174. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 175. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 176. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 177. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 179. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 181. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 182. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 183. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 184. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 185. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 186. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 187. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 188. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 189. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 190. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 191. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 192. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 193. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 194. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 195. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 197. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 199. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 200. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 201. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 202. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 203. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 205. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 206. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 207. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 208. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 209. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 210. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 211. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 212. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 213. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 215. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 217. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 218. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 219. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 220. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 221. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 244. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 245. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 246. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 247. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 248. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 249. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 250. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 251. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 253. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 255. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 256. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 257. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 258. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 259. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 261. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 262. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 263. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 264. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 265. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 266. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 267. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 268. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 269. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 271. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 273. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 274. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 275. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 276. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 277. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 279. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 280. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 281. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 282. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 283. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 284. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 285. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 286. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 287. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 289. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 291. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 292. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 293. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 294. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 295. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 297. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 298. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 299. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 300. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 301. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 302. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 303. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 304. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 305. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 307. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 309. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 310. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 311. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 312. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 313. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 314. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 315. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 316. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 317. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 318. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 319. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 320. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 321. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 322. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 323. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-20